Novartis Pharmaceuticals Corp. has announced a $390 million settlement that will end alleged violations of the federal False Claims Act (FCA). The lawsuit filed under the FCA alleged that No... Read more
The settlement comes about five years after Novartis agreed to a $420 million settlement of FCA and misdemeanor criminal allegations involving off-label promotion and kickbacks to doctors. Read more
After years of investigating Swiss drugmaker Novartis, the Justice Department and 11 states are demanding almost $3.4 billion in damages and fines in a False Claims Act lawsuit involving ill... Read more
Specialty pharmacy Accredo Health Group Inc. will pay $14.9 million to settle state regulators’ claims it participated in a patient referral kickback scheme with Novartis Pharmaceutica... Read more
It has been reported widely that there is a great deal of “outsourcing” in manufacturing and technical support. But beyond the economic impact of sending jobs overseas, this practice could n... Read more
The Italian Competition Authority (ICA), the country’s antitrust enforcer, has fined two Swiss drugmakers, Hoffmann-La Roche Ltd. and Novartis AG, more than $250 million for colluding to dir... Read more
Genoptix Inc., a subsidiary of Novartis AG, will pay nearly $8 million to end a putative securities class action alleging the company misrepresented customer demand for diagnostic cancer tes... Read more
A California federal judge has upheld a $2.2 million verdict against Novartis Pharmaceutical Corp. This ruling came in a woman’s lawsuit over a jaw injury allegedly caused by the bone... Read more
U.S. District Judge Mark. R. Hornak has ruled that Pennsylvania product liability law permitting unlimited punitive damages controls three suits alleging Novartis Pharmaceutical’s bone drug,... Read more
Drugmakers Johnson & Johnson and Novartis AG have been fined a total of €16.3 million ($22.4 million) by European regulators for entering into an anti-competitive agreement to delay the... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.